BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 34794144)

  • 1. TATI, TAT-2, and CRP as Prognostic Factors in Colorectal Cancer.
    Björkman K; Kaprio T; Beilmann-Lehtonen I; Stenman UH; Böckelman C; Haglund C
    Oncology; 2022; 100(1):22-30. PubMed ID: 34794144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-associated trypsin inhibitor (TATI) and tumor-associated trypsin-2 (TAT-2) predict outcomes in gastric cancer.
    Kasurinen A; Laitinen A; Kokkola A; Stenman UH; Böckelman C; Haglund C
    Acta Oncol; 2020 Jun; 59(6):681-688. PubMed ID: 32124669
    [No Abstract]   [Full Text] [Related]  

  • 3. Increased serum levels of tumour-associated trypsin inhibitor independently predict a poor prognosis in colorectal cancer patients.
    Gaber A; Nodin B; Hotakainen K; Nilsson E; Stenman UH; Bjartell A; Birgisson H; Jirström K
    BMC Cancer; 2010 Sep; 10():498. PubMed ID: 20849596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumour-associated trypsin inhibitor TATI is a prognostic marker in colorectal cancer.
    Koskensalo S; Hagström J; Louhimo J; Stenman UH; Haglund C
    Oncology; 2012; 82(4):234-41. PubMed ID: 22508321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumour-associated trypsin inhibitor, carcinoembryonic antigen and acute-phase reactant proteins CRP and alpha1-antitrypsin in patients with gastrointestinal malignancies.
    Solakidi S; Dessypris A; Stathopoulos GP; Androulakis G; Sekeris CE
    Clin Biochem; 2004 Jan; 37(1):56-60. PubMed ID: 14675563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of trypsinogen-1, trypsinogen-2, and tumor-associated trypsin inhibitor in ovarian cancer: prognostic study on tissue and serum.
    Paju A; Vartiainen J; Haglund C; Itkonen O; von Boguslawski K; Leminen A; Wahlström T; Stenman UH
    Clin Cancer Res; 2004 Jul; 10(14):4761-8. PubMed ID: 15269150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-associated trypsin inhibitor (TATI) in patients with colorectal carcinoma. A critical comparison with CEA.
    Catarino M; Conde R
    Scand J Clin Lab Invest Suppl; 1991; 207():43-6. PubMed ID: 1780689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postoperative CEA is a better prognostic marker than CA19-9, hCGβ or TATI after resection of colorectal liver metastases.
    Peltonen R; Österlund P; Lempinen M; Nordin A; Stenman UH; Isoniemi H
    Tumour Biol; 2018 Jan; 40(1):1010428317752944. PubMed ID: 29378497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of radiation therapy on tissue and serum concentrations of tumour associated trypsin inhibitor and their prognostic significance in rectal cancer patients.
    Gaber A; Stene C; Hotakainen K; Nodin B; Palmquist I; Bjartell A; Stenman UH; Jeppsson B; Johnson LB; Jirström K
    Radiat Oncol; 2011 Aug; 6():100. PubMed ID: 21864386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum tumour associated trypsin inhibitor, as a biomarker for survival in renal cell carcinoma.
    Tornberg SV; Nisen H; Järvinen P; Järvinen R; Kilpeläinen TP; Taari K; Stenman UH; Visapää H
    Scand J Urol; 2020 Oct; 54(5):413-419. PubMed ID: 32748674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concomitant tumor expression of EGFR and TATI/SPINK1 associates with better prognosis in colorectal cancer.
    Koskensalo S; Louhimo J; Hagström J; Lundin M; Stenman UH; Haglund C
    PLoS One; 2013; 8(10):e76906. PubMed ID: 24204699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Relationship between the Tissue Expression of TLR2, TLR4, TLR5, and TLR7 and Systemic Inflammatory Responses in Colorectal Cancer Patients.
    Beilmann-Lehtonen I; Hagström J; Kaprio T; Stenman UH; Strigård K; Palmqvist R; Gunnarsson U; Böckelman C; Haglund C
    Oncology; 2021; 99(12):790-801. PubMed ID: 34515203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumour-associated trypsin inhibitor (TATI) in patients with colorectal cancer: a comparison with CEA, CA 50 and CA 242.
    Pasanen P; Eskelinen M; Kulju A; Penttilä I; Janatuinen E; Alhava E
    Scand J Clin Lab Invest; 1995 Apr; 55(2):119-24. PubMed ID: 7667604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative plasma plasminogen activator inhibitor type-1 and serum C-reactive protein levels in patients with colorectal cancer. The RANX05 Colorectal Cancer Study Group.
    Nielsen HJ; Christensen IJ; Sørensen S; Moesgaard F; Brünner N
    Ann Surg Oncol; 2000 Sep; 7(8):617-23. PubMed ID: 11005561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of tumor-associated trypsin inhibitor (TATI) and human chorionic gonadotropin-β (hCGβ) in patients with hepatocellular carcinoma.
    Lyytinen I; Lempinen M; Nordin A; Mäkisalo H; Stenman UH; Isoniemi H
    Scand J Gastroenterol; 2013 Sep; 48(9):1066-73. PubMed ID: 23889187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of the combined expression of tumor-associated trypsin inhibitor (TATI) and p53 in patients with bladder cancer undergoing radical cystectomy.
    Liu A; Xue Y; Liu F; Tan H; Xiong Q; Zeng S; Zhang Z; Gao X; Sun Y; Xu C
    Cancer Biomark; 2019; 26(3):281-289. PubMed ID: 31594208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High expression of tumour-associated trypsin inhibitor correlates with liver metastasis and poor prognosis in colorectal cancer.
    Gaber A; Johansson M; Stenman UH; Hotakainen K; Pontén F; Glimelius B; Bjartell A; Jirström K; Birgisson H
    Br J Cancer; 2009 May; 100(10):1540-8. PubMed ID: 19384300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of preoperative serum vascular endothelial growth factor, interleukin-6, and C-reactive protein level in colorectal cancer.
    Kwon KA; Kim SH; Oh SY; Lee S; Han JY; Kim KH; Goh RY; Choi HJ; Park KJ; Roh MS; Kim HJ; Kwon HC; Lee JH
    BMC Cancer; 2010 May; 10():203. PubMed ID: 20465852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biology and function of tumor-associated trypsin inhibitor, TATI.
    Stenman UH; Koivunen E; Itkonen O
    Scand J Clin Lab Invest Suppl; 1991; 207():5-9. PubMed ID: 1780691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum Serine Peptidase Inhibitor Kazal-Type 1, Trypsinogens 1 to 3, and Complex of Trypsin 2 and α1-Antitrypsin in the Diagnosis of Severe Acute Pancreatitis.
    Rainio M; Lindström O; Penttilä A; Itkonen O; Kemppainen E; Stenman UH; Kylänpää L
    Pancreas; 2019 Mar; 48(3):374-380. PubMed ID: 30747826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.